发明名称 |
COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2 |
摘要 |
The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
|
申请公布号 |
US2011065775(A1) |
申请公布日期 |
2011.03.17 |
申请号 |
US20100883049 |
申请日期 |
2010.09.15 |
申请人 |
ISIS PHARMACEUTICALS, INC. |
发明人 |
BHANOT SANJAY;GEARY RICHARD S.;MCKAY ROBERT;MONIA BRETT P.;SETH PUNIT P.;SIWKOWSKI ANDREW M.;SWAYZE ERIC E.;WANCEWICZ EDWARD |
分类号 |
A61K31/7052;A61P3/00;A61P3/04;A61P3/10;C07H21/00;C12N15/113 |
主分类号 |
A61K31/7052 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|